Danaher Corporation (DHR) Position Increased by Taurus Asset Management LLC
Taurus Asset Management LLC raised its position in shares of Danaher Corporation (NYSE:DHR) by 12.2% during the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 189,337 shares of the conglomerate’s stock after acquiring an additional 20,630 shares during the quarter. Danaher makes up approximately 2.5% of Taurus Asset Management LLC’s holdings, making the stock its 11th largest position. Taurus Asset Management LLC’s holdings in Danaher were worth $16,241,000 at the end of the most recent reporting period.
A number of other institutional investors have also recently bought and sold shares of DHR. Flossbach Von Storch AG boosted its position in Danaher by 44.7% during the 2nd quarter. Flossbach Von Storch AG now owns 5,782,019 shares of the conglomerate’s stock valued at $487,945,000 after acquiring an additional 1,785,810 shares in the last quarter. Arrowstreet Capital Limited Partnership lifted its holdings in shares of Danaher by 16,410.0% during the second quarter. Arrowstreet Capital Limited Partnership now owns 1,485,901 shares of the conglomerate’s stock valued at $125,395,000 after purchasing an additional 1,476,901 shares during the last quarter. Findlay Park Partners LLP lifted its holdings in shares of Danaher by 52.9% during the third quarter. Findlay Park Partners LLP now owns 4,117,348 shares of the conglomerate’s stock valued at $353,186,000 after purchasing an additional 1,425,000 shares during the last quarter. Koch Industries Inc. lifted its holdings in shares of Danaher by 29,127.3% during the second quarter. Koch Industries Inc. now owns 1,404,665 shares of the conglomerate’s stock valued at $1,388,000 after purchasing an additional 1,399,859 shares during the last quarter. Finally, JPMorgan Chase & Co. lifted its holdings in shares of Danaher by 86.1% during the third quarter. JPMorgan Chase & Co. now owns 3,011,947 shares of the conglomerate’s stock valued at $256,136,000 after purchasing an additional 1,393,165 shares during the last quarter. 76.32% of the stock is currently owned by institutional investors and hedge funds.
Danaher Corporation (NYSE DHR) opened at $93.18 on Friday. Danaher Corporation has a 1-year low of $77.45 and a 1-year high of $94.82. The firm has a market cap of $64,816.47, a P/E ratio of 23.95, a P/E/G ratio of 2.22 and a beta of 1.02. The company has a debt-to-equity ratio of 0.42, a current ratio of 1.43 and a quick ratio of 1.00.
Danaher (NYSE:DHR) last announced its quarterly earnings data on Thursday, October 19th. The conglomerate reported $1.00 earnings per share for the quarter, topping analysts’ consensus estimates of $0.95 by $0.05. Danaher had a net margin of 13.36% and a return on equity of 11.29%. The company had revenue of $4.53 billion during the quarter, compared to analyst estimates of $4.47 billion. During the same period in the previous year, the business earned $0.87 EPS. The firm’s revenue for the quarter was up 9.6% on a year-over-year basis. analysts anticipate that Danaher Corporation will post 3.99 earnings per share for the current year.
The company also recently disclosed a quarterly dividend, which will be paid on Friday, January 26th. Investors of record on Friday, December 29th will be issued a $0.14 dividend. The ex-dividend date is Thursday, December 28th. This represents a $0.56 dividend on an annualized basis and a yield of 0.60%. Danaher’s payout ratio is currently 16.52%.
In other Danaher news, SVP Daniel Raskas sold 37,870 shares of Danaher stock in a transaction that occurred on Thursday, November 16th. The shares were sold at an average price of $93.33, for a total value of $3,534,407.10. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CAO Robert S. Lutz sold 11,189 shares of Danaher stock in a transaction that occurred on Monday, October 23rd. The stock was sold at an average price of $91.66, for a total transaction of $1,025,583.74. Following the completion of the sale, the chief accounting officer now directly owns 18,314 shares of the company’s stock, valued at approximately $1,678,661.24. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 273,810 shares of company stock valued at $25,218,813. 12.20% of the stock is owned by company insiders.
Several equities analysts have recently issued reports on DHR shares. Goldman Sachs Group reiterated a “neutral” rating and set a $83.00 target price on shares of Danaher in a report on Tuesday, September 26th. Credit Suisse Group lifted their target price on shares of Danaher from $93.00 to $96.00 and gave the company an “outperform” rating in a report on Friday, October 20th. J P Morgan Chase & Co reiterated an “overweight” rating and set a $95.00 target price on shares of Danaher in a report on Friday, September 8th. Robert W. Baird lifted their target price on shares of Danaher from $87.00 to $97.00 and gave the company an “outperform” rating in a report on Friday, October 20th. Finally, Morgan Stanley lifted their target price on shares of Danaher from $95.00 to $98.00 and gave the company an “overweight” rating in a report on Friday, October 20th. One investment analyst has rated the stock with a sell rating, four have issued a hold rating, thirteen have given a buy rating and one has issued a strong buy rating to the company. The company presently has an average rating of “Buy” and an average price target of $93.31.
Danaher Company Profile
Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through four segments: Life Sciences, which offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines; Diagnostics; which offers analytical instruments, reagents, consumables, software and services; Dental, which provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, and Environmental & Applied Solutions, which consists of various lines of business, including water quality and product identification.
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR).
Receive News & Ratings for Danaher Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher Corporation and related companies with Analyst Ratings Network's FREE daily email newsletter.